To see the effect of Ayurveda drug in the eye disease.

â??A prospective randomized comparative clinical study to evaluate the efficacy of sarpikshodranjana in sirotpata W.S.R. to episclaritis

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017035

Enrollment

Registered

2019-01-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients who are suffering from Episcleritis

Interventions

Intervention1: Aampachan Paniya 2.5 liter / day for 7 days: Mustak Sunthi Dhanyak Control Intervention1: sarpikshodranjan 1 drop / every evening for 7 day: Go ghrit Makshika

Eligibility

Inclusion criteria

Inclusion criteria: Patient with signs and symptoms of sirotpata and episcleritis described as per Ayurveda and Modern parlance

Exclusion criteria

Exclusion criteria: Patient with scleral involvement. Patient with other ocular pathology. patient in whom Anjana is contraindicated.

Design outcomes

Primary

Measure	Time frame
Raktaraji Ushanata Savedana decreasedTimepoint: 1 year	—

Secondary

Measure	Time frame
to treat the patient who are suffering from sirotpata w.s.r. to episcleritis.Timepoint: 1 year	—

Countries

India

Contacts

Public ContactDr Prabhakar Vardhan

National Instittue of Ayurveda Jaipur

shalakya007@gmail.com9461065960

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026